Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units ; volume:23 ; number:1 ; day:29 ; month:1 ; year:2022 ; pages:1-10 ; date:12.2022
BMC nephrology ; 23, Heft 1 (29.1.2022), 1-10, 12.2022
- Urheber
-
Matusik, Elodie
Lemtiri, Justine
Wabont, Guillaume
Lambiotte, Fabien
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-022-02678-x
- URN
-
urn:nbn:de:101:1-2022050807494707177203
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Matusik, Elodie
- Lemtiri, Justine
- Wabont, Guillaume
- Lambiotte, Fabien
- SpringerLink (Online service)
Ähnliche Objekte (12)
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
![Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
Optimization of beta-lactam dosing through targeted therapeutic drug monitoring
β-lactam antibiotic concentrations during continuous renal replacement therapy
Renal replacement therapy does have impact on beta-lactam clearance
Lacosamide dosing in patients receiving continuous renal replacement therapy
Adsorption and caspofungin dosing during continuous renal replacement therapy
International survey of antibiotic dosing and monitoring in adult intensive care units
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy